시장보고서

상품코드

1606413

자궁내막암 시장 : 암 유형별, 치료의 유형별, 진단 방법별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Endometrial Cancer Market, By Type of Cancer, By Type of Therapy, By Diagnosis Method, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

자궁내막암 시장 규모는 2023년에 263억 9,453만 달러에 달하며, 2024-2032년 CAGR 5.80%로 확대

자궁내막암 시장 - 시장 역학

자궁내막암의 유병률 증가가 시장 확대를 촉진할 것으로 예측됩니다.

자궁내막암 환자 수가 증가함에 따라 효율적인 진단 툴와 서비스에 대한 수요가 증가하고 있습니다. 여기에는 생검과 함께 초음파 및 MRI와 같은 영상 기술의 활용이 포함됩니다. 인지도를 높이고 선별검사를 실시하면 조기 진단을 촉진하여 치료 결과를 개선하는 데 필수적인 조기 진단을 촉진할 수 있습니다. 세계암연구기금(World Cancer Research Fund International)에 따르면 2022년에 보고된 자궁내막암 신규 환자 수는 420,368명입니다. 현재 진행 중인 연구개발은 치료 방법의 발전과 함께 시장에 성장 기회를 제공할 수 있습니다. 그러나 의료 서비스에 대한 제한된 접근성은 시장 성장의 걸림돌이 될 수 있습니다.

자궁내막암 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032) 동안 연평균 약 5.80%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

암 유형별로는 자궁내막암이 22023년 가장 높은 시장 점유율을 차지했습니다.

치료 유형별로는 2023년 화학요법이 주요 치료 유형으로 부상했습니다.

진단 방법별로는 2023년 생검이 주요 유형으로 나타났습니다.

지역별로는 북미가 2023년 주요 수입원이었습니다.

자궁내막암 시장 - 세분화 분석 :

세계 자궁내막암 시장은 암의 유형, 치료법, 진단 방법, 지역별로 구분됩니다.

시장은 암의 유형에 따라 자궁내막암, 자궁육종, 기타 등 두 가지로 나뉩니다. 자궁내막암이 시장을 장악하고 있습니다. 자궁내막암은 자궁 내막(자궁내막)에 발생하는 암의 일종입니다. 자궁내막암은 자궁내막암의 대부분을 차지하며 주로 폐경 후 여성에서 진단됩니다.

시장은 치료 유형에 따라 면역 요법, 방사선 요법, 화학요법 및 기타 세 가지 부문으로 나뉩니다. 면역 요법, 방사선 요법, 화학요법 및 기타. 화학요법은 진행성, 재발성 또는 공격적인 유형의 자궁내막암에 대한 주요 치료법 중 하나로 널리 인정받고 있습니다.

시장은 진단 방법에 따라 생검, 골반 초음파 검사, 자궁경 검사, CT 스캔, 기타 등 4가지 범주로 나뉩니다. 생검은 시장에서 우세한 위치를 차지하고 있습니다. 자궁내막암의 조기 발견과 진단에서 생검의 중요성이 가장 중요하며, 치료법 선택과 진단 툴 및 방법에 대한 수요에 직접적인 영향을 미치기 때문입니다.

자궁내막암 시장 - 지역적 인사이트

북미가 시장을 주도하고 있는데, 이는 주로 진단 방법의 발전으로 인한 것입니다. 이 지역은 최첨단 진단 기술을 갖춘 수많은 암 치료 센터와 전문 시설을 포함한 강력한 의료 시스템을 갖추고 있습니다. 이러한 인프라는 진단과 치료를 포함한 암 치료에 대한 종합적인 접근을 용이하게 합니다. 매년 약 40만 명의 환자가 NCI 지정 암센터에서 암 진단을 받고 있습니다. 유럽은 인식 제고와 검진 프로그램 시행으로 인해 두 번째로 높은 시장 성장률을 보이는 지역입니다. 세계 시장은 각 지역에서 인식, 진단 능력 및 치료 옵션이 지속적으로 강화됨에 따라 더욱 성장할 것으로 예상됩니다.

자궁내막암 시장 - 경쟁 구도:

자궁내막암 시장은 진단, 치료 및 환자 예후 개선에 초점을 맞춘 새로운 기술 혁신에 힘입어 높은 수준의 경쟁을 보이고 있습니다. 생검 기기, 화학요법제, 표적치료제, 면역요법 등의 분야에서 많은 기업이 시장 점유율을 놓고 경쟁하고 있습니다. 면역치료, 표적치료, 병용요법 등 새로운 치료 옵션을 창출하기 위해 연구개발에 많은 투자가 이루어지고 있습니다. 액체생검, 유전자 검사 등의 치료법은 조기 발견 및 개인 맞춤형 치료 전략의 가능성을 점점 더 인정받고 있습니다. 규제 당국의 승인 절차를 효율적으로 진행할 수 있는 기업은 특히 면역 치료와 같이 빠르게 발전하는 분야에서 경쟁 우위를 점할 수 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 자궁내막암 업계

경쟁 대시보드
기업 개요
- Pfizer Inc.
- Bristol Myers Squibb Company
- Merck &Co. Inc.
- Novartis International AG
- AstraZeneca PLC
- Genentech Inc.(Roche)
- GlaxoSmithKline PLC
- Johnson &Johnson
- Eli Lilly and Company
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Sanofi SA
- Hoffmann-La Roche Ltd.
- Exelixis Inc.
- Others

제12장 애널리스트의 전방위 전망

KSA 24.12.24

REPORT HIGHLIGHT

Endometrial Cancer Market size was valued at USD 26,394.53 million in 2023, expanding at a CAGR of 5.80% from 2024 to 2032.

Endometrial cancer is a form of cancer that originates from the cellular growth within the uterus, which is the hollow, pear-shaped organ in the pelvis responsible for fetal development. In the United States, it is the most prevalent cancer impacting the reproductive system of women and individuals assigned female at birth (AFAB). This type of cancer predominantly occurs following menopause. Approximately 3% of women and individuals with AFAB will be diagnosed with uterine cancer at some stage in their lives, with around 65,000 new cases reported annually.

Endometrial Cancer Market- Market Dynamics

The increasing prevalence of endometrial cancer is anticipated to propel market expansion.

As the number of endometrial cancer cases escalates, there is an increasing demand for efficient diagnostic tools and services. This encompasses the utilization of imaging technologies, such as ultrasound and MRI, along with biopsy procedures. Improved awareness and screening practices can facilitate earlier diagnoses, which are crucial for enhancing treatment outcomes. According to the World Cancer Research Fund International, there were 420,368 new cases of endometrial cancer reported in 2022. The ongoing research and development, along with advancements in treatment modalities, may present growth opportunities for the market. However, limited access to healthcare services could hinder market growth.

Endometrial Cancer Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.80% over the forecast period (2024-2032)

Based on Type of Cancer segmentation, Endometrial Carcinoma was predicted to show maximum market share in the year 2023

Based on Type of Therapy segmentation, Chemotherapy was the leading type in 2023

Based on Diagnosis Method segmentation, Biopsy was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Endometrial Cancer Market- Segmentation Analysis:

The Global Endometrial Cancer Market is segmented on the basis of Type of Cancer, Type of Therapy, Diagnosis Method, and Region.

The market is divided into two categories based on the Type of Cancer: Endometrial Carcinoma, Uterine Sarcomas, and Others. Endometrial Carcinoma dominates the market. Endometrial carcinoma is a type of cancer that originates in the lining of the uterus (endometrium). It accounts for the majority of uterine cancers and is usually diagnosed in postmenopausal women.

The market is classified into three segments according to the Type of Therapy: Immunotherapy, Radiation Therapy, Chemotherapy, and Others. The Chemotherapy segment holds a dominant position within the market. It is widely recognized as one of the primary treatment options for advanced, recurrent, or aggressive types of endometrial cancer.

The market is segmented into four categories according to the Diagnosis Method: Biopsy, Pelvic Ultrasound, Hysteroscopy, CT scan, and others. Biopsy holds a predominant position in the market. The significance of biopsies in the early detection and diagnosis of endometrial cancer is paramount, as they directly affect treatment choices and the demand for diagnostic tools and methodologies.

Endometrial Cancer Market- Geographical Insights

North America leads the market, primarily due to advancements in diagnostic methodologies. The region is characterized by a strong healthcare system that includes numerous established cancer treatment centers and specialized facilities, all equipped with cutting-edge diagnostic technologies. This infrastructure facilitates a holistic approach to cancer care, encompassing both diagnosis and treatment. Annually, around 400,000 patients are diagnosed with cancer at NCI-Designated Cancer Centers. Europe ranks as the second largest region for market growth, attributed to heightened awareness and the implementation of screening programs. The global market is anticipated to grow further as awareness, diagnostic capabilities, and treatment alternatives continue to enhance across various regions.

Endometrial Cancer Market- Competitive Landscape:

The Endometrial Cancer Market exhibits a high level of competition, propelled by innovations in diagnostics, treatment modalities, and emerging technologies focused on enhancing patient outcomes. Numerous firms are competing for market share in sectors such as biopsy instruments, chemotherapeutic drugs, targeted therapies, and immunotherapies. Significant investments in research and development are being made to create novel treatment options, including immunotherapies, targeted therapies, and combination approaches. Advancements such as liquid biopsy and genetic testing are increasingly recognized for their potential in early detection and personalized treatment strategies. Companies that can efficiently navigate the regulatory approval process are positioned to gain a competitive edge, particularly in rapidly evolving areas like immunotherapy.

Recent Developments:

On February 5, 2024, Novartis announced that it has reached an agreement to initiate a voluntary public takeover bid for MorphoSys AG, a biopharmaceutical company based in Germany that specializes in the development of innovative oncology treatments.

A recent trial of an innovative antibody drug, which administers powerful chemotherapy directly to cancer cells, is progressing to a phase III study for patients suffering from advanced or recurrent endometrial cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOMETRIAL CANCER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc.
Bristol Myers Squibb Company
Merck & Co. Inc.
Novartis International AG
AstraZeneca PLC
Genentech Inc. (Roche)
GlaxoSmithKline PLC
Johnson & Johnson
Eli Lilly and Company
AbbVie Inc.
Teva Pharmaceutical Industries Ltd.
Bayer AG
Sanofi S.A.
Hoffmann-La Roche Ltd.
Exelixis Inc.
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY TYPE OF CANCER- MARKET ANALYSIS, 2019 - 2032

Endometrial Carcinoma
Uterine Sarcomas
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY TYPE OF THERAPY- MARKET ANALYSIS, 2019 - 2032

Immunotherapy
Radiation Therapy
Chemotherapy
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY DIAGNOSIS METHOD- MARKET ANALYSIS, 2019 - 2032

Biopsy
Pelvic Ultrasound
Hysteroscopy
CT scan
Others

GLOBAL ENDOMETRIAL CANCER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Endometrial Cancer Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Endometrial Cancer Market Snippet by Type of Cancer
- 2.1.2. Endometrial Cancer Market Snippet by Type of Therapy
- 2.1.3. Endometrial Cancer Market Snippet by Diagnosis Method
- 2.1.4. Endometrial Cancer Market Snippet by Country
- 2.1.5. Endometrial Cancer Market Snippet by Region
2.2. Competitive Insights

3. Endometrial Cancer Key Market Trends

3.1. Endometrial Cancer Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Endometrial Cancer Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Endometrial Cancer Market Opportunities
3.4. Endometrial Cancer Market Future Trends

4. Endometrial Cancer Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Endometrial Cancer Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Endometrial Cancer Market Landscape

6.1. Endometrial Cancer Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Endometrial Cancer Market - By Type of Cancer

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type of Cancer, 2023 & 2032 (%)
- 7.1.2. Endometrial Carcinoma
- 7.1.3. Uterine Sarcomas
- 7.1.4. Others

8. Endometrial Cancer Market - By Type of Therapy

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type of Therapy, 2023 & 2032 (%)
- 8.1.2. Immunotherapy
- 8.1.3. Radiation Therapy
- 8.1.4. Chemotherapy
- 8.1.5. Others

9. Endometrial Cancer Market - By Diagnosis Method

9.1. Overview
- 9.1.1. Segment Share Analysis, By Diagnosis Method, 2023 & 2032 (%)
- 9.1.2. Biopsy
- 9.1.3. Pelvic Ultrasound
- 9.1.4. Hysteroscopy
- 9.1.5. CT scan
- 9.1.6. Others

10. Endometrial Cancer Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Endometrial Cancer Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Endometrial Cancer Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Endometrial Cancer Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Endometrial Cancer Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Endometrial Cancer Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type of Cancer, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Type of Therapy, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Diagnosis Method, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Endometrial Cancer Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Bristol Myers Squibb Company
- 11.2.3. Merck & Co. Inc.
- 11.2.4. Novartis International AG
- 11.2.5. AstraZeneca PLC
- 11.2.6. Genentech Inc. (Roche)
- 11.2.7. GlaxoSmithKline PLC
- 11.2.8. Johnson & Johnson
- 11.2.9. Eli Lilly and Company
- 11.2.10. AbbVie Inc.
- 11.2.11. Teva Pharmaceutical Industries Ltd.
- 11.2.12. Bayer AG
- 11.2.13. Sanofi S.A.
- 11.2.14. Hoffmann-La Roche Ltd.
- 11.2.15. Exelixis Inc.
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us